7th Annual Summit on Controlled Substances – Regulation, Litigation, and Enforcement

7th Annual Summit on Controlled Substances – Regulation, Litigation, and Enforcement is organized by American Conference Institute (ACI), C5 Group Inc. and will be held from Jan 26 - 27, 2026 at Virgin Hotels New York City, New York City, New York, United States of America.

Description:
The 2026 program equips you to navigate a volatile year ahead. Expect insights on DEA enforcement, quota reforms, suspicious order monitoring, and emerging therapies.

Why You Can’t Miss It
Hear firsthand from regulators, in-house counsel, compliance leaders, and enforcement specialists. Walk away from tailored sessions that empower you to:

• Decode shifting DOJ & DEA priorities to reduce legal and regulatory exposure
• Prepare for telehealth’s next chapter under the pending Special Registration rule
• Align your SOM programs with new DEA compliance standards
• Manage supply chain and quota risks through smarter strategies
• Stay ahead of the prosecution curve as federal and state enforcement intensifies

What You’ll Gain

• Forward-looking insights to shape your 2026 legal, compliance, and operations roadmap
• Proven solutions for telemedicine prescribing, enforcement readiness, and enterprise risk
• Trusted expertise from past and current DEA, FDA, DOJ officials, top law firms, and leading in-house teams
• Cross-functional connections spanning pharma, biotech, telehealth, distributors, retail, and government